• Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
Supercomputing’s Impact on Precision Medicine Discussed at Recent SC16 Conference

Information on the cutting-edge of precision medicine and health technology was the topic of discussion at the recently held SC16, the premier international conference showcasing how high performance computing, networking, storage and analysis leads to advances in scientific discovery, research, education and commerce. The event is funded by ACM (Association for Computing Machinery) and IEEE Computer Society.

The focus was placed on precision medicine due to ongoing advances that are opening up more options for treating difficult and complex diseases. Treatments that are in near-future development include highly customized pills designed for personal use, extracting and reintroducing strengthened body cells, and growing organs from stem cells using 3D printed scaffolds. The field is even gaining interest from the US government which invested $210 million in its own precision medicine sector.

“Emerging and more precise biomedical research tools are advancing discovery, while efforts to ethically collect, analyze and share the data behind disease are also positioning scientists to find the next new treatments,” says Steve Conway, one of the leading panelists and a supercomputing analyst from IDC.

In regards to the other panelists, Conway stated that “combining supercomputing technology with research and physician input will improve quality of life, increase efficacies and mitigate or eliminate the burdens of disease for millions of patients.”

SC16 took place on November 14 in Salt Lake City, Utah featuring a wide array of participants from major biotech and science companies.